دورية أكاديمية
The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy.
العنوان: | The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy. |
---|---|
المؤلفون: | Wijnakker R; Department of Internal Medicine, Tergooi Medical Center, Hilversum and Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands; Department of Infectious Diseases and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: rwijnakker@tergooi.nl., van Maaren MS; Section Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands., Bode LGM; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands., Bulatovic M; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Hendriks BJC; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Loogman MCM; Dutch College of General Practitioners, the Netherlands., Lutgens SPM; Department of Medical Microbiology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Middel A; Department of Internal Medicine, University Medical Center Groningen, Groningen, the Netherlands., Nieuwhof CMG; Department of Internal Medicine and Allergology, Maastricht University Medical Center, Maastricht, the Netherlands., Roelofsen EE; Department of Clinical Pharmacy, Medical Center Haaglanden, The Hague, the Netherlands., Schoones JW; Leiden University Medical Center, Leiden, the Netherlands., Sigaloff KCE; Department of Infectious Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands., Sprikkelman AB; Department of Pediatric Pulmonology and Allergology, University Medical Center Groningen, Groningen, the Netherlands., de Vrankrijker LMM; Section Infectious Diseases, Department of Pediatric Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands., de Boer MGJ; Department of Infectious Diseases and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: M.G.J.de_Boer@lumc.nl. |
المصدر: | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Jul; Vol. 29 (7), pp. 863-875. Date of Electronic Publication: 2023 Apr 15. |
نوع المنشور: | Journal Article; Practice Guideline |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2015- : London : Elsevier Original Publication: Paris : Decker Europe, c1995- |
مواضيع طبية MeSH: | Antimicrobial Stewardship* , Drug Hypersensitivity*/diagnosis , Hypersensitivity*/drug therapy, Adult ; Child ; Humans ; Anti-Bacterial Agents/adverse effects ; beta-Lactams/adverse effects |
مستخلص: | Objectives: Prudent handling of reported antibiotic allergies is an important aspect of antibiotic stewardship. The Dutch Working Party on Antibiotic Policy (SWAB) constituted a multidisciplinary expert committee to provide evidence-based recommendations for bedside decision-making in antibiotic therapy in patients that report an antibiotic allergy. Methods: The guideline committee generated 12 key questions, most of which were population, intervention, comparison, and outcome questions relevant to both children and adults with suspected antibiotic allergies. For each question, a systematic literature search was performed and reviewed for the best available evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. The quality of evidence was graded from very low to high, and recommendations were formulated in structured discussions as strong or weak. Results: Sixty recommendations were provided for suspected allergy to β-lactam antibiotics (BLAs) and non-β-lactam antibiotics. Owing to the absence of randomized controlled trials in this field, the underlying evidence was predominantly graded as low or very low. Available data support that a detailed allergy history should always be performed and critically appraised. When cross-allergy between BLA groups is not to be expected due to the absence of molecular similarity of the side chains, the patient can be safely exposed to the alternative BLA. An exception to this rule is severe delayed-type reactions in which re-exposure to a BLA should only be considered after consultation with a multidisciplinary team. Conclusions: Accumulated scientific data now support a more liberal approach that better balances the benefits of treatment with first choice and usually smaller spectrum antibiotics with appropriate avoidance of antibiotics in case of a truly high risk of a (severe) allergic reaction. In The Netherlands, a formal guideline was developed that provides recommendations for the approach toward suspected allergy to BLA and frequently used non-β-lactam antibiotics, thereby strongly supporting antimicrobial stewardship. (Copyright © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.) |
فهرسة مساهمة: | Keywords: Antibiotic allergy; Antimicrobial stewardship; Delabeling; Non–β-lactam antibiotics; Relabeling; β-Lactam |
المشرفين على المادة: | 0 (Anti-Bacterial Agents) 0 (beta-Lactams) |
تواريخ الأحداث: | Date Created: 20230417 Date Completed: 20230630 Latest Revision: 20230630 |
رمز التحديث: | 20230701 |
DOI: | 10.1016/j.cmi.2023.04.008 |
PMID: | 37068548 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1469-0691 |
---|---|
DOI: | 10.1016/j.cmi.2023.04.008 |